Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome

被引:0
|
作者
Kyeong Ho Yun
Myung Ho Jeong
Seok Kyu Oh
Sang Jae Rhee
Eun Mi Park
Eun Mi Lee
Nam Jin Yoo
Nam-Ho Kim
Young Keun Ahn
Jin-Won Jeong
机构
[1] Wonkwang University Hospital,Department of Cardiovascular Medicine
[2] Chonnam National University Hospital,Department of Cardiovascular Medicine
来源
Heart and Vessels | 2009年 / 24卷
关键词
Percutaneous coronary angioplasty; Stent; C-reactive protein; Inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
Percutaneous coronary intervention (PCI) provokes an inflammatory reaction, as shown by increased concentrations of plasma C-reactive protein (CRP) after PCI. However, the changes of CRP levels after PCI in patients with acute coronary syndrome (ACS) have not been well evaluated. We evaluated the characteristics of the patients with elevated CRP response after PCI and whether an increase in CRP after PCI predicts long-term prognosis in patients with ACS. We studied consecutive 360 patients with ACS who underwent elective coronary stenting. Inflammatory response to PCI was calculated as the difference between the peak postprocedural hsCRP level and the preprocedural hsCRP level (ΔCRP). Twelve months follow-up data were obtained and clinical outcomes were compared with ΔCRP. In receiver operating characteristics analyses, the cutoff point of ΔCRP for major adverse cardiac events (MACE) was 3.0 mg/l, which yielded sensitivity of 61.7% and specificity of 69.7%. The patients with ΔCRP > 3 mg/l revealed higher incidence of myocardial infarction (37.7 vs 14.6%, P < 0.001), and ACC/AHA type B2/C lesion (81.5 vs 68.7%, P = 0.006) than in patients with low ΔCRP. White blood cell count, low-density lipoprotein cholesterol, peak creatinine kinase-MB, and peak troponin T were significantly elevated in patients with ΔCRP > 3 mg/l than in those with ≤3 mg/l. There was significant correlation between ΔCRP and the changes in troponin T after PCI (r = 0.210, P < 0.001). An increase in hsCRP > 3 mg/l after PCI had a higher predictive value for the occurrence of MACE than low hsCRP elevation (hazard ratio 2.1, P = 0.005). In multivariate analysis, ΔCRP and peak troponin T were independent predictors of MACE (P < 0.001 and P = 0.013, respectively). In conclusion, postprocedural hsCRP elevation >3 mg/l was associated with higher incidence of MACE in patients with ACS. ΔCRP determinations may be of value for risk stratification after PCI.
引用
收藏
页码:175 / 180
页数:5
相关论文
共 50 条
  • [31] Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel
    Hajsadeghi, Shokoufeh
    Chitsazan, Mandana
    Chitsazan, Mitra
    Salehi, Negar
    Amin, Ahmad
    Bidokhti, Arash Amin
    Babaali, Nima
    Bordbar, Armin
    Hejrati, Maral
    Moghadami, Samar
    CLINICAL MEDICINE INSIGHTS-CARDIOLOGY, 2016, 10 : 149 - 155
  • [32] High Sensitivity C-Reactive Protein and Outcomes Following Percutaneous Coronary Intervention in Contemporary Practice
    Herrmann, Joerg
    Lennon, Ryan J.
    Barsness, Gregory W.
    Sandhu, Gurpreet S.
    Gulati, Rajiv
    Best, Patricia J. M.
    Sorajja, Paul
    Bresnahan, John F.
    Mathew, Verghese
    Bell, Malcolm R.
    Prasad, Abhiram
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2012, 5 (06) : 783 - 790
  • [33] Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study
    Kaura, Amit
    Hartley, Adam
    Panoulas, Vasileios
    Glampson, Ben
    Shah, Anoop S. V.
    Davies, Jim D.
    Mulla, Abdulrahim R.
    Woods, Kerrie
    Omigie, Joe
    Shah, Anoop
    Thursz, Mark W.
    Elliott, Paul
    Hemmingway, Harry M.
    Williams, Bryan
    Asselbergs, Folkert
    O'Sullivan, Michael O.
    Lord, Graham
    Trickey, Adam P.
    Sterne, Jonathan A. C.
    Haskard, Dorian M.
    Melikian, Narbeh
    Francis, Darrel
    Koenig, Wolfgang S.
    Shah, Ajay M.
    Kharbanda, Rajesh
    Perera, Divaka
    Patel, Riyaz
    Channon, Keith
    Mayet, Jamil
    Khamis, Ramzi
    PLOS MEDICINE, 2022, 19 (02)
  • [34] Fibrinogen with high-sensitivity C-reactive protein: A combined prediction biomarker for acute coronary syndrome risk assessment
    Makmool, Chananikan
    Pussadhamma, Burabha
    Leuangwatthananon, Wit
    Howhan, Songpol
    Komanasin, Nantarat
    SCIENCEASIA, 2022, 48 (01): : 8 - 14
  • [35] High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease
    Rosenson, RS
    Koenig, W
    CURRENT OPINION IN CARDIOLOGY, 2002, 17 (04) : 325 - 331
  • [36] High Level of Pre-procedural High-Sensitivity C-Reactive Protein Predicts Stent Thrombosis After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction
    Jeong, Hae Chang
    Ahn, Youngkeun
    Cho, Jae Yeong
    Cho, Sang Cheol
    Jang, Su Young
    Song, Ji Eun
    Yoo, Jong Hyun
    Hong, Young Joon
    Kim, Ju Han
    Jeong, Myung Ho
    Chae, Shung Chull
    Chae, Jei Keon
    Cho, Myeong Chan
    Kim, Young Jo
    Kim, Chong Jin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B148 - B148
  • [37] Prognostic Impact of Baseline High-Sensitivity C-Reactive Protein in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Based on Body Mass Index
    Ahmed, Khurshid
    Jeong, Myung Ho
    Chakraborty, Rabin
    Cho, Kyung Hoon
    Sim, Doo Sun
    Hong, Young Joon
    Ahn, Youngkeun
    Hachinohe, Daisuke
    Cho, Myeong Chan
    Kim, Chong Jin
    Kim, Young Jo
    KOREAN CIRCULATION JOURNAL, 2012, 42 (03) : 164 - 172
  • [38] High-sensitivity C-reactive protein in patients with metabolic syndrome
    Guven, Aytekin
    Cetinkaya, Ali
    Aral, Murat
    Sokmen, Gulizar
    Buyukbese, Mehmet Akif
    Guven, Alanur
    Koksal, Nurhan
    ANGIOLOGY, 2006, 57 (03) : 295 - 302
  • [39] Baseline high-sensitivity C-reactive protein and glycosylated hemoglobinA1c predict adverse outcomes in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
    Tang, Xiao-Fang
    Yuan, De -Shan
    Zhu, Pei
    Xu, Na
    Yao, Yi
    Wang, Pei-Zhi
    Chen, Yan
    Gao, Li-Jian
    Song, Lei
    Yang, Yue-Jin
    Gao, Run -Lin
    Zhao, Xue-Yan
    Yuan, Jin-Qing
    HELIYON, 2024, 10 (01)
  • [40] High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events
    Futterman, LG
    Lemberg, L
    AMERICAN JOURNAL OF CRITICAL CARE, 2002, 11 (05) : 482 - 486